Sarah Potash, MD
Obstetrics & Gynecology · Cedar Knolls, NJNPI 1003920216
Payments from drug & device makers
What this record shows
25 manufacturers reported payments, led by Celularity Inc. at 57.1% of the total. Reporting peaked in 2021 at $1,367 and has fallen 82.3% since, to $242 in 2025.
Across 78 payments — averaging $36.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$2K
- Mayne Pharma Commercial LLC$144
- Exeltis, USA Inc.$109
- Astellas Pharma US Inc$86
- Myovant Sciences Inc.$84
- Baxter Healthcare$78
- plus $714 from 19 others
What the payments were for
- Speaking & faculty fees$1,60057%
- Food & beverage$1,23143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 8 | $1,615 |
| Mayne Pharma Commercial LLC | 11 | $144 |
| Exeltis, USA Inc. | 7 | $109 |
| Astellas Pharma US Inc | 4 | $86 |
| Myovant Sciences Inc. | 6 | $84 |
| Baxter Healthcare | 2 | $78 |
| Agile Therapeutics, Inc. | 5 | $78 |
| AbbVie | 5 | $72 |
| Sumitomo Pharma America, Inc. | 4 | $58 |
| Davol Inc. | 1 | $52 |
| Pfizer | 3 | $48 |
| Hologic Sales And Service, LLC | 2 | $48 |
| Exact Sciences | 2 | $45 |
| Millicent US Inc | 2 | $42 |
| Organon | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Bayer | 1 | $28 |
| Coopersurgical, Inc. | 2 | $27 |
| Avion Pharmaceuticals | 2 | $26 |
| Mimedx Group, Inc. | 1 | $23 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $15 |
How this compares
$2,831 in reported general payments places this provider in the 80th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Cedar Knolls
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.